JohnLamondMD

PubMed

• 1 citations
  Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experienc...
  A. Ricco, Gabrielle Barbera, Rachelle Lanciano, Jing Feng, Alexandra L. Hanlon, Alicia Lozano, Michael Good, Stephen Arrigo, John Lamond, Jun Yang> ;Frontiers in Oncology. 2020 Sep 25
• 8 citations
  Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations.
  A. Ricco, Sara Barlow, Jing Feng, Janson Jacob, Alicia Lozano, Alexandra L. Hanlon, Stephen Arrigo, O. Obayomi-Davies, John Lamond, Jun Yang, Rachelle Lanciano> ;Advances in Radiation Oncology. 2020 Jun 25
• 4 citations
  Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event and Salvage of Second Brain Metastatic Event in a Community Setting...
  Shaharyar Ahmad, A. Ricco, Royce Brown, Alexandra L. Hanlon, Jun Yang, Jing Feng, Michael Stanley, Richard Buonocore, Aubrey Okpaku, Steven Arrigo, John Lamond, Luther...> ;Frontiers in Oncology. 2017 Mar 9
• 2 citations
  The effect of whole-brain radiation (WBI) and Karnofsky performance status (KPS) on survival of patients receiving stereotactic radiosurgery (SRS) for second brain met...
  D. R. Brown, Rachelle Lanciano, Cory Heal, A.L. Hanlon, Jun Yang, Jing Feng, M. Stanley, R. Buonocore, A. Okpaku, W. Ding, Steven Arrigo, John Lamond, L. Brady> ;Journal of Radiation Oncology. 2017 Mar 1
• 23 citations
  Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy
  Shaakir Hasan, A. Ricco, Kaylette Jenkins, Rachelle Lanciano, Alexandra L. Hanlon, John Lamond, Jun Yang, Jing Feng, Michael Good, Joel Noumoff, Luther W. Brady> ;Frontiers in Oncology. 2016 Nov 22
• 11 citations
  Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer
  Caspian Oliai, Matthew Bernetich, Luther W. Brady, Jun Yang, Alexandra L. Hanlon, John Lamond, Steven Arrigo, Michael Good, Michael Mooreville, Bruce B. Garber, Rachel...> ;Journal of Radiation Oncology. 2016 Jan 23
• 12 citations
  Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
  Cory Heal, William Ding, John Lamond, Michael Wong, Rachelle Lanciano, Stacy Su, Jun Yang, Jing Feng, Stephen Arrigo, Deborah Markiewicz, Alexandra L. Hanlon, Luther W...> ;Frontiers in Oncology. 2015 Jun 30
• 25 citations
  Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience
  Shaakir Hasan, Eda Chen, Rachelle Lanciano, Jun Yang, A.L. Hanlon, John Lamond, Stephen Arrigo, William Ding, Michael Mikhail, Arezoo Ghaneie, Luther W. Brady> ;Frontiers in Oncology. 2015 May 15
• 15 citations
  SBRT: an opportunity to improve quality of life for oligometastatic prostate cancer
  Gregory Azzam, Rachelle Lanciano, Steve Arrigo, John Lamond, William Ding, Jun Yang, Alexandra L. Hanlon, Michael Good, Luther W. Brady> ;Frontiers in Oncology. 2015 May 5
• 34 citations
  Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses
  Nisha R. Patel, Rachelle Lanciano, Karna Sura, Jun Yang, John Lamond, Jing Feng, Michael Good, Edward J. Gracely, Lydia Komarnicky, Luther W. Brady> ;Journal of Radiation Oncology. 2015 Jan 1
• 27 citations
  SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN ...
  Matthew Bernetich, Caspian Oliai, Rachelle Lanciano, Alexandra L. Hanlon, John Lamond, Stephen Arrigo, Jun Yang, Michael Good, Jing Feng, Royce Brown, Bruce B. Garber,...> ;Frontiers in Oncology. 2014 Nov 11
• 8 citations
  Effect of Fractionation in Stereotactic Body Radiation Therapy Using the Linear Quadratic Model
  Jun Yang, John Lamond, Jack F. Fowler, Rachelle Lanciano, Jing Feng, Luther W. Brady> ;International Journal of Radiation Oncology, Biology, Physics. 2013 May 1
• 61 citations
  Stereotactic body radiation therapy for the primary treatment of localized prostate cancer
  Caspian Oliai, Rachelle Lanciano, Brian Sprandio, Jun Yang, John Lamond, Steven Arrigo, Michael Good, Michael Mooreville, Bruce B. Garber, Luther W. Brady> ;Journal of Radiation Oncology. 2013 Mar 1
• 33 citations
  Stereotactic Body Radiation Therapy for Patients with Heavily Pretreated Liver Metastases and Liver Tumors
  Rachelle Lanciano, John Lamond, Jun Yang, Jing Feng, Steven Arrigo, Michael Good, Luther W. Brady> ;Frontiers in Oncology. 2012 Mar 9
• 30 citations
  Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer.
  Natasa C. Townsend, Bradley J. Huth, William Ding, Bruce B. Garber, Michael Mooreville, Stephen Arrigo, John Lamond, Luther W. Brady> ;American Journal of Clinical Oncology. 2011 Feb 1
• 25 citations
  Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.
  Jun Yang, Jack F. Fowler, John Lamond, Rachelle Lanciano, Jing Feng, Luther W. Brady> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Jul 1
• A "Red Shell" concept of increased radiation damage hazard to normal tissues just outside the PTV target volume.
  Jack F. Fowler, Jun Yang, John Lamond, Rachelle Lanciano, Jing Feng, Luther W. Brady> ;Radiotherapy and Oncology. 2010 Mar 1
• 23 citations
  Angiosarcoma of the head and neck managed by a combination of multiple biopsies to determine tumor margin and radiation therapy. Report of three cases and review of th...
  Ricardo Bullen, Paul O. Larson, Anya Landeck, Stephen Nychay, Stephen N. Snow, Paul G. Hazen, Timothy J. Kinsella, John Lamond> ;Dermatologic Surgery. 1998 Oct 1
• 180 citations
  A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases
  Minesh P. Mehta, William R. Noyes, Bruce A. Craig, John Lamond, Richard M. Auchter, Molly C. French, Mark R. Johnson, Allan B. Levin, Behnam Badie, Ian Robbins, Timoth...> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Sep 1
• 49 citations
  The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: Report of a synergistic effect between topotecan and radiation
  John Lamond, Minesh P. Mehta, David A. Boothman> ;Journal of Neuro-Oncology. 1996 Oct 1
• 34 citations
  Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitors
  John Lamond, Meizhi Wang, Timothy J. Kinsella, David A. Boothman> ;International Journal of Radiation Oncology, Biology, Physics. 1996 Sep 1
• 41 citations
  Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation.
  John Lamond, Meizhi Wang, Timothy J. Kinsella, David A. Boothman> ;International Journal of Radiation Oncology, Biology, Physics. 1996 Sep 1
• 373 citations
  A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
  Richard M. Auchter, John Lamond, Eben Alexander, John M. Buatti, Rick Chappell, William A. Friedman, Timothy J. Kinsella, Allan B. Levin, William R. Noyes, Christopher...> ;International Journal of Radiation Oncology, Biology, Physics. 1995 Jan 1
• Join now to see all